Back to all assets

Align Technology ALGN

equity

Price History

The shaded fan is where this price has historically travelled over the months after a close like today’s. It is not a forecast: it has no view on direction, only on distance.

$96.91$283.67$470.42$657.18
2021-102026-09 · $147.61

Over 3 months from Sep 2026, roughly two-thirds of past moves landed between $114.3 and $190.63; nine in ten between $96.91 and $224.83.

Tested against this asset’s own history: across 294 past 3-month windows, the price actually landed inside the two-thirds band 72% of the time. The gap from 68% is the model’s error — real returns have fatter tails than the maths assumes, so the band gets breached more often than it claims.

Time underwater

How far below its previous all-time high the price sat, each month. 0% means a new high.

-86.9%-57.9%-29.0%-0.0%
2001-012026-09 · -79.2%

Worst drawdown: −87%, peaking Jan 2001 and bottoming Oct 2002 — 33 months below the prior high before recovering.

DCA Backtest

Invested
$30,900
Value today
$250,880
Return
+711.9%
Months invested
309

Scenarios

Inflation — the same contributions merely keeping pace with CPI would be $44,597 today, so the real (inflation-adjusted) return is +462.5%.

Lump sum instead — $30,900 all at once in Jan 2001: $337,863 (+993.4%) — lump sum came out ahead.

Worst timing — same monthly amount started at the all-time high (Aug 2021): $4,015 on $6,200 invested (-35.2%).

⚠ Price returns only — dividends are not included. This understates the true return of dividend-paying shares, and any comparison against crypto (which pays no dividends) is biased against equities by roughly the dividend yield, compounded.

If this saved you a spreadsheet — buy me a coffee.

Every start month at once

Each cell is the return-to-date of £/$/€100-a-month DCA started that month. Click a cell to load it in the backtest above. The ringed cell is the all-time-high start — the worst timing scenario.

JFMAMJJASOND
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Legend:−50%−20%0%+50%+200%+1000%worst timing (ATH)Selected 2001-01: +711.9%

About Align Technology

Align Technology, Inc. is an American manufacturer of 3D digital scanners and Invisalign clear aligners used in orthodontics and restorative workflow. It was founded in 1997 and is headquartered in Tempe, Arizona. The company manufactures the aligners in Juarez, Mexico, and its scanners in Israel and China. The company is best known for its Invisalign system, which is a clear aligner treatment used to straighten teeth. (Wikipedia)

It's a listed company categorised under health care and health care supplies, with a market cap of about $10.5B.

It rates Medium-High Risk at 2.6/5, meaning real but ordinary risk — the kind most mainstream assets carry, with some factors scoring poorly.

What pushes the score up: market / volatility (4.7/5) and sector / regulatory (3.0/5).

Scoring well: earnings quality at 1.0/5.

Not yet researched: leverage / financial, concentration, governance. These are excluded from the score rather than guessed, so the real risk may be higher than what’s shown.

Ratings summarise sourced facts against fixed rules — not investment advice, and no substitute for your own diligence.

Risk Profile

Medium-High Risk(2.6/5)60% rated

How these ratings work

Market / Volatility4.7/5 · weight 20%
  • Annualised volatility (3yr)4/551.2
  • Max drawdown from ATH5/586.9
  • Beta vs S&P 5005/52.1
Liquidity1.0/5 · weight 15%
  • Avg daily $ volume1/5164.1m
  • Float % of shares outstandingnot yet researched
Leverage / Financialunrated · weight 20%
  • Debt / equitynot yet researched
  • Interest coverage (EBIT / interest)not yet researched
Earnings Quality1.0/5 · weight 15%
  • 3yr EPS volatility1/52.7
Concentrationunrated · weight 10%
  • Largest customer, % of revenuenot yet researched
  • Geographic revenue concentrationnot yet researched
Governanceunrated · weight 10%
  • Board independence %not yet researched
  • Share structurenot yet researched
  • Litigation / audit historynot yet researched
Sector / Regulatory3.0/5 · weight 10%
  • Sector regulatory exposure3/5elevated

Linked Assets

Same sector, or return-correlated — worth knowing what else might move if this one does.